Comerica Bank
BBP icon

Comerica Bank’s Virtus Biotech ETF BBP Stock Holding History

Comerica Bank’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$17.3K Buy
217
+111
+105% +$8.43K ﹤0.01% 3121
2025
Q3 		$7.42K Buy
+106
New +$6.94K ﹤0.01% 3320

Other funds holding BBP

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ARC
Advisor Resource Council Dallas, Texas $309M AUM 22.32% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
CFP
Comprehensive Financial Planning East Petersburg, Pennsylvania $144M AUM 25.61% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Comerica Bank's BBP Position: Q4 2025 in Review

Comerica Bank increased its Virtus Biotech ETF (BBP) stake by 105% in Q4 2025, buying an estimated $8.43K and bringing the position to 217 shares worth $17.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3121.

Comerica Bank first reported a position in BBP in Q3 2025 and has held it in 2 quarters since. 20 funds tracked by Wall St. Rank hold BBP as of Q4 2025.

  • Comerica Bank held 217 shares of Virtus Biotech ETF worth $17.3K as of Q4 2025.
  • Comerica Bank bought 111 Virtus Biotech ETF shares in Q4 2025, an estimated $8.43K.
  • Virtus Biotech ETF made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3121 holding.
  • Comerica Bank first reported a position in Virtus Biotech ETF in Q3 2025 and has held it in 2 quarters since.
  • 20 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.